Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-α and retinoids

被引:0
作者
T Brodowicz
C Wiltschke
D Kandioler-Eckersberger
T W Grunt
M Rudas
S M Schneider
M Hejna
A Budinsky
C C Zielinski
机构
[1] Clinical Division of Oncology,Department of Medicine I
[2] Chair of medical Experimental Oncology,Department of Clinical Pathology
[3] Department of Surgery,undefined
[4] University Hospital,undefined
[5] Ludwig Boltzmann Institute for Clinical Experimental Oncology,undefined
来源
British Journal of Cancer | 1999年 / 80卷
关键词
apoptosis; soft tissue sarcoma; interferon-α; retinoids; p53;
D O I
暂无
中图分类号
学科分类号
摘要
Uncontrolled proliferation and a defect of apoptosis constitute crucial elements in the development and progression of tumours. Among many other biological response modifiers known to influence these mechanisms, the efficacy of retinoids and interferons in the treatment of various malignant entities is currently matter of discussion. In the present study, we have investigated the effects of 9-cis-retinoic acid (9cRA), 13-cis-retinoic acid (13cRA), all-trans-retinoic acid (tRA) and interferon-α on proliferation and apoptosis of human soft tissue sarcoma (STS) cell lines HTB-82 (rhabdomyosarcoma), HTB-91 (fibrosarcoma), HTB-92 (liposarcoma), HTB-93 (synovial sarcoma) and HTB-94 (chondrosarcoma) in relation to p53 genotype as well as p53 expression. HTB-91, HTB-92 and HTB-94 STS cells exhibited mutant p53, whereas wild-type p53 was found in HTB-93 STS cells, and a normal p53 status in HTB-82 STS cells, carrying a silent point mutation only. Interferon-α, irrespective of p53 status, inhibited the proliferation of all five cell lines dose- and time-dependently. Similarly, 9cRA, 13cRA and tRA decreased the proliferation of HTB-82 and HTB-93 STS cells, whereas the proliferation of p53-mutated HTB-91, HTB-92 and HTB-94 STS cells remained unchanged. Furthermore, only 9cRA and tRA were capable of inducing apoptosis in HTB-82 and HTB-93 STS cells, whereas HTB-91, HTB-92 and HTB-94 STS cells did not undergo apoptosis under the influence of 9cRA or tRA. Retinoic acid receptor (RAR)-α and RAR-β mRNA were not detectable by Northern blot analysis in the five STS cell lines, whereas mRNA for the universal retinoic acid receptor, RAR-γ, was expressed in all STS cell lines indicating that retinoid resistance was not associated with a lack of RAR expression. Apoptosis was not induced by interferon-α or 13cRA in any of the five STS cell lines tested. Our results indicate that within the panel of tested STS cell lines, inhibition of proliferation and induction of apoptosis result from different mechanisms which differ in their dependence upon the presence of intact p53.
引用
收藏
页码:1350 / 1358
页数:8
相关论文
共 277 条
[1]  
Aas T(1996)Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients Nat Med 2 811-814
[2]  
Borresen AL(1995)p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts Proc Natl Acad Sci USA 92 8493-8497
[3]  
Geisler S(1993)An intergroup phase III randomized study of doxorubicin and dacarbacine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas J Clin Oncol 11 1276-1285
[4]  
Smith-Sorensen B(1997)Adjuvant therapy of sarcomas of soft tissue Semin Oncol 24 556-560
[5]  
Johnson H(1995)Expression of human all-trans-retinoic acid receptor beta and its ligand-binding domain in Biochem J 308 353-359
[6]  
Varhaug JE(1995)Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy Nat Med 1 1029-1034
[7]  
Akslen LA(1990)Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas Cancer 66 862-867
[8]  
Lonning PE(1995)γ-Radiation-induced apoptosis in human colorectal adenoma and carcinoma cell lines can occur in the absence of wild-type p53 Oncogene 10 2391-2396
[9]  
Agarwal ML(1997)Re: isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-γ and melphalan for non-resectable extremity soft tissue sarcomas: a multicenter trial J Clin Oncol 15 2174-2175
[10]  
Agarwal A(1995)Growth factor modulation of p53-mediated growth arrest versus apoptosis Gene Dev 9 600-611